These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 8039097)

  • 1. Research advances in the biology of Alzheimer's disease.
    Tabaton M
    Clin Geriatr Med; 1994 May; 10(2):249-55. PubMed ID: 8039097
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The amyloid peptide and its precursor in Alzheimer's disease.
    Octave JN
    Rev Neurosci; 1995; 6(4):287-316. PubMed ID: 8845971
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amyloid-dependent triosephosphate isomerase nitrotyrosination induces glycation and tau fibrillation.
    Guix FX; Ill-Raga G; Bravo R; Nakaya T; de Fabritiis G; Coma M; Miscione GP; Villà-Freixa J; Suzuki T; Fernàndez-Busquets X; Valverde MA; de Strooper B; Muñoz FJ
    Brain; 2009 May; 132(Pt 5):1335-45. PubMed ID: 19251756
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tau paired helical filaments from Alzheimer's disease brain and assembled in vitro are based on beta-structure in the core domain.
    Barghorn S; Davies P; Mandelkow E
    Biochemistry; 2004 Feb; 43(6):1694-703. PubMed ID: 14769047
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of paired helical filaments (PHFs) found in Alzheimer's disease using freeze-drying/rotary shadowing.
    Appelt DM; Balin BJ
    J Struct Biol; 1993; 111(2):85-95. PubMed ID: 8130039
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High sensitivity analysis of amyloid-beta peptide composition in amyloid deposits from human and PS2APP mouse brain.
    Güntert A; Döbeli H; Bohrmann B
    Neuroscience; 2006 Dec; 143(2):461-75. PubMed ID: 17008022
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Involvement of tau protein kinase in amyloid-beta-induced neurodegeneration].
    Ishiguro K
    Rinsho Byori; 1998 Oct; 46(10):1003-7. PubMed ID: 9816911
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Advances in molecular biology and clinical study of amyloid precursor protein for Alzheimer's disease].
    Xu BG; Wu X
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2004 Apr; 26(2):201-9. PubMed ID: 15171563
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Filamentous proteins in Alzheimer's disease: new insights through molecular biology.
    Klunk WE; Abraham DJ
    Psychiatr Dev; 1988; 6(2):121-52. PubMed ID: 2907135
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An aluminum-based rat model for Alzheimer's disease exhibits oxidative damage, inhibition of PP2A activity, hyperphosphorylated tau, and granulovacuolar degeneration.
    Walton JR
    J Inorg Biochem; 2007 Sep; 101(9):1275-84. PubMed ID: 17662457
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isoaspartate formation and neurodegeneration in Alzheimer's disease.
    Shimizu T; Watanabe A; Ogawara M; Mori H; Shirasawa T
    Arch Biochem Biophys; 2000 Sep; 381(2):225-34. PubMed ID: 11032409
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Recent advances in Alzheimer's disease research--amyloid precursor protein trafficking, processing, and mutations in Alzheimer's disease linked genes].
    Fukatsu R; Tsuzuki K; Hayashi Y; Takamaru Y; Sasaki N; Yoshida T; Hatakeyama Y; Fuji N; Takahata N
    Hokkaido Igaku Zasshi; 1997 Jan; 72(1):3-11. PubMed ID: 9086357
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assembly of microtubule-associated protein tau into Alzheimer-like filaments induced by sulphated glycosaminoglycans.
    Goedert M; Jakes R; Spillantini MG; Hasegawa M; Smith MJ; Crowther RA
    Nature; 1996 Oct; 383(6600):550-3. PubMed ID: 8849730
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Therapy of Alzheimer disease].
    Kovács T
    Neuropsychopharmacol Hung; 2009 Mar; 11(1):27-33. PubMed ID: 19731816
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Alzheimer's disease: lesions and their progression].
    Duyckaerts C; Colle MA; Delatour B; Hauw JJ
    Rev Neurol (Paris); 1999; 155 Suppl 4():S17-27. PubMed ID: 10637934
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Biological characteristics of amyloid precursor protein and Alzheimer's disease].
    Fukatsu R; Tsuzuki K; Takamaru Y; Hayashi Y; Sasaki N; Yoshida T; Midorikawa Y; Fujii N; Takahata N
    Rinsho Byori; 1996 Mar; 44(3):213-24. PubMed ID: 8857163
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Advances in molecular pathology of Alzheimer's disease].
    Coria-Balanzat F
    Rev Neurol; 2006 Mar 1-15; 42(5):306-9. PubMed ID: 16538595
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modification of tau to an Alzheimer's type protein interferes with its interaction with microtubules.
    González C; Farías G; Maccioni RB
    Cell Mol Biol (Noisy-le-grand); 1998 Nov; 44(7):1117-27. PubMed ID: 9846894
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The involvement of the ubiquitin system in Alzheimer's disease (review).
    Pallares-Trujillo J; Lopez-Soriano FJ; Argilés JM
    Int J Mol Med; 1998 Jul; 2(1):3-15. PubMed ID: 9854137
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Animal models of Alzheimer's disease: a road full of pitfalls].
    Delacourte A; Buée L
    Psychol Neuropsychiatr Vieil; 2005 Dec; 3(4):261-70. PubMed ID: 16316817
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.